CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


23-August-2016
Cerilliant now offers Certified Spiking Solutions® of the benzodiazepines Delorazepam and Clorazepate dipotassium.

Delorazepam, 100 ug/mL D-142
100 ug/mL in Acetonitrile

Delorazepam, also known as chlordesmethyldiazepam, is a long acting benzodiazepine. Delorazepam is also an active metabolite of the benzodiazepine drugs diclazepam and cloxazolam. This Certified Spiking Solution® is suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing.

Clorazepate dipotassium C-156
1.0 mg/mL (as clorazepate) in Methanol

A certified analytical reference solution suitable for use in benzodiazepine testing methods by GC/MS or LC/MS for applications in clinical toxicology, urine drug testing or forensic analysis. Clorazepate dipotassium is a long-acting benzodiazepine with anxiolytic, anticonvulsant, sedative and hypnotic properties. Clorazepate dipotassium, marketed under the brand name Tranxene®, is a prodrug for nordiazepam, which is produced as an active metabolite.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn